Antibodies, antibody-drug conjugates, and uses thereof

TW202637580APending Publication Date: 2026-09-16VELAVIGO (SHANGHAI) LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114146061
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-11-26
Filing Date
2025-11-25
Publication Date
2026-09-16

Smart Images

  • Figure TWG2TA001076529_001
    Figure TWG2TA001076529_001
  • Figure TWG2TA001076529_002
    Figure TWG2TA001076529_002
  • Figure TWG2TA001076529_003
    Figure TWG2TA001076529_003
Patent Text Reader

Abstract

The present invention relates to antigen-binding molecules and antibody-drug conjugates (ADCs), and more specifically to antibodies and antibody-drug conjugates targeting CLDN18.2 and / or CDH17, as well as compositions comprising said antibodies or ADCs and their therapeutic applications.
Need to check novelty before this filing date? Find Prior Art